Mannosidosis

These are rare genetic conditions where the body doesn't have enough of a specific enzyme called mannosidase. This enzyme helps break down certain sugars. When it's missing or not working properly, it can cause problems, especially in the kidneys and eyes.

Condition

What people with Mannosidosis report

Every report comes from a Lived member, sent anonymously.

Have you tried Enzyme Replacement Therapy for Mannosidosis?

NameHow it went

About Mannosidosis

What It Is

Mannosidosis is a rare inherited condition in which the body cannot fully break down certain sugar chains attached to proteins. Normally an enzyme called a mannosidase clears these chains inside lysosomes, the parts of each cell that digest and recycle material. When the enzyme is missing or works poorly, the sugars build up and gradually harm cells in many organs. This places mannosidosis among the lysosomal storage disorders. There are two forms. Alpha-mannosidosis, estimated to affect about 1 in 500,000 people, can cause hearing loss, frequent infections, bone and joint problems, distinctive facial features, poor coordination, muscle weakness, learning difficulties and sometimes psychiatric symptoms such as depression or hallucinations. Beta-mannosidosis is rarer still. Nearly everyone with it has intellectual disability, and some have seizures, behavior difficulties, hearing loss, frequent infections or small dark red spots on the skin. Severity varies widely. Some forms appear in infancy and progress quickly, while others are recognized later in childhood or adulthood and progress slowly. The mildest cases may cause few symptoms.

Causes & Risk Factors

Mannosidosis is caused by changes in a single gene: MAN2B1 in alpha-mannosidosis and MANBA in beta-mannosidosis. It is inherited in an autosomal recessive pattern, which means a child is affected only when they receive a changed copy of the gene from both parents. Parents who each carry one copy usually have no symptoms. When both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is a carrier, and a 25% chance of a child who neither has the condition nor carries it. Nothing a parent did during pregnancy causes mannosidosis. In alpha-mannosidosis, episodes of psychiatric symptoms can be set off by stresses such as surgery, emotional upset or a change in routine, but these are triggers for symptoms, not causes of the disease.

How It's Diagnosed

Because the early signs, such as hearing loss, repeated ear and chest infections or delayed development, are common in childhood, mannosidosis is often suspected only when several appear together. A clinician who suspects it can order a blood test that measures the enzyme's activity in white blood cells. In alpha-mannosidosis, activity is typically only 5% to 10% of normal. Genetic testing that finds changes in both copies of the gene confirms the diagnosis and identifies the form. Once the family's gene changes are known, brothers and sisters can be tested, including before birth, so that a child who is affected can be identified and treated early. Relatives can also learn whether they are carriers.

Treatment Options

Care is led by a team that usually includes a metabolic or genetics specialist. For alpha-mannosidosis, the main targeted treatment is velmanase alfa (Lamzede), an enzyme replacement therapy that supplies a lab-made version of the missing enzyme. It is given as an intravenous infusion once a week, for life. It is approved for the effects of the disease outside the brain and nervous system. Studies, though small, report gains in breathing, strength, endurance and quality of life, and some report improved hearing and fewer infections. It does little to prevent decline in thinking and learning. The label carries a warning about severe allergic reactions, including anaphylaxis, so infusions are given where staff can treat a reaction, sometimes after medicine to prevent one. It may harm an unborn baby, so pregnancy is ruled out before starting and contraception is advised during treatment. A hematopoietic stem cell transplant, which replaces the bone marrow with a donor's so the body can make the enzyme, is sometimes offered in severe alpha-mannosidosis. Done early, before complications develop, it can help preserve development and steady bone problems. It carries serious risks, including infection, graft-versus-host disease (donor cells attacking the body) and death, which rise with age. Velmanase alfa is approved only for alpha-mannosidosis. For both forms, much of care addresses specific problems: hearing aids or ear tubes, prompt treatment of infections, physical therapy for strength and balance, bone-strengthening medicines when bones thin, eye care, school and developmental support, and treatment for mood or psychiatric symptoms.

What to Expect

The course depends on the form and on when symptoms began. People with the most severe infant-onset form of alpha-mannosidosis often do not survive childhood. Those with later-onset forms tend to progress slowly over decades, and some live into their fifties. The mildest cases may cause few problems. Long-term results of enzyme replacement are still being studied, so its effect on outlook is not yet clear. Life with mannosidosis usually involves regular follow-up. Typical checks include hearing tests every one to two years, physical therapy reviews of strength and coordination, bone density scans every few years, eye exams, blood tests, and attention to mood, sleep and behavior. People receiving enzyme replacement also have a weekly infusion visit. Because the condition touches many parts of life, families often benefit from coordinated care, educational support and connection with rare disease organizations.

When to Seek Help

Ask about an evaluation for mannosidosis when a child has a combination of hearing loss, frequent infections, delayed development or coordination problems, and unusual bone changes, or when a sibling has been diagnosed. Contact the care team promptly about new depression, hallucinations, confusion or sudden changes in behavior; infections that keep returning; or new trouble walking, growing weakness or loss of skills already learned, which can reflect progression or fluid building up in the brain (hydrocephalus). If, after leaving an infusion, a person develops swelling of the face or throat, trouble breathing, bluish skin or faintness, call 911.

Questions to Ask Your Doctor

  1. 1.Which form of mannosidosis is this, and what does that suggest about how it may progress?
  2. 2.Is enzyme replacement or a stem cell transplant appropriate at this age and stage, and what can each realistically achieve?
  3. 3.Which specialists should be part of our care team, and how often will each check-up happen?
  4. 4.Should brothers, sisters or other relatives be tested, and would genetic counseling help with family planning?
  5. 5.What school, therapy or support services can we arrange now?

Last reviewed • Oct 2026

Educational content, not medical advice.